Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium
- Chester B. Good, MD, MPH; and
- Lisa Longo, PharmD
- From Veterans Administration Pittsburgh Healthcare System, Pittsburgh, PA 15240.
TO THE EDITOR:
The decision of Niewoehner and colleagues (1) to compare tiotropium with placebo instead of with ipratropium for prevention of exacerbations of chronic obstructive pulmonary disease (COPD) is problematic for several reasons. The authors state they designed the study “to reflect community practice.” However, community practice includes the use …
RSS Feeds









